UCAP, Inc. was a multi-state provider of mortgage lending and brokerage services. In April 2004, UCAP announced that it believed it would have to restate its financial statements for the periods ending September 30, 2002; December 30, 2002; and March 31, 2003. Six months later, UCAP’s wholly-owned, principal operating subsidiary filed for Chapter 11 bankruptcy. UCAP soon ceasеd operations, and its stock was delisted in 2005.
*1113 Joseph McAdams, Florian Homin', Richard P. Smyth, and their affiliated companies sued several UCAP executives and Moore Stephens Frost, PLC — UCAP’s outside auditor from November 2001 to July 2003. The investors claimed that the executives and MSF defrauded them by inducing them to invest in UCAP through misrepresentations and false statements about UCAP’s financial condition.
The district court
1
eventually dismissed the second amended complaint, finding that the investors did not meet the heightened pleading standards of Rule 9 of the Federal Rules of Civil Procedure, and of the Private Securities Litigation Reform Act of 1995 (“PSLRA”), Pub.L. No. 104-67, 109 Stat. 737. This court dismissed an earlier appeal.
See McAdams v. McCord,
I.
This court reviews de novo a dismissal for failure to state a claim. Fed. R.Civ.P. 12(b)(6);
Ferris, Baker Watts, Inc. v. Ernst & Young, LLP,
Section 10(b) and Rule 10b-5 prohibit fraudulent conduct in the sale and purchase of securities.
See
15 U.S.C. § 783(b); 17 C.F.R. § 240.10b-5. Claims require (1) a material misrepresentation or omission, (2) scienter, i.e., a wrongful state of mind, (3) a connection with the purchase or sale of a security, (4) reliance, (5) economic loss, and (6) loss causation.
Dura Pharm., Inc. v. Broudo,
The district court held that the complaint failed to plead with particularity the circumstances of MSF’s alleged fraud, as well as the facts giving rise to a strong inference of scienter. The court aсcordingly dismissed the investors’ federal, state, and common law fraud claims. The court did not address MSF’s argument that the complaint also did not adequately plead loss causation. This court, however, may affirm the district court’s judgment
*1114
“on any basis supported by the record.”
K-tel,
II.
The complaint contains numerous allegedly fraudulent statements by the executives in press releаses and UCAP’s financial statements. The complaint further states that MSF assisted the executives to distort UCAP’s financial statements to make the company appear like it was, a thriving, growing business, when it was not. Section 10(b), however, imposes liability only on a person who makes a material misstatement or omission, not on a person who aids in making the misstatement or omission.
Central Bank of Denver v. First Interstate Bank of Denver,
MSF made two statements, according to the complaint. On UCAP’s 2001 and 2002 annual 10-K reports, filed in January 2002 and January 2003, respectively, MSF stated that it conducted its audit in accordance with generally accepted accounting рrinciples and that in MSF’s opinion, UCAP’s financial statements fairly presented the financial position of UCAP. 2 The complaint further alleges that MSF knew that UCAP’s financial statеments were not prepared in accordance with GAAP and knew that UCAP’s actual financial condition was far weaker than was presented by the financial stаtements. Therefore, because MSF issued “clean” audit opinions when it knew UCAP’s financial statements were not accurate, MSF allegedly made false statements with scienter. This court need not decide whether the complaint adequately states with particularity facts giving rise to a strong inference that MSF acted with scienter when it issued its audit opinions because, as discussed below, the complaint fails to sufficiently plead loss causation.
A complaint must “provide a defendant with some indication of the loss and the causal connection that the plaintiff has in mind.”
Dura,
The complaint alleges that Mc-Adams invested over $3 million in UCAP, that Homm invested over $6 million, and that Smyth invested $2 million. The complaint then broadly alleges that “as a direct and proximatе result of Defendants’ fraudulent misrepresentations and omission of material facts, Plaintiffs have been damaged in amounts to be determined at trial but which exceed $10 million.” This threadbare, conclusory statement does not sufficiently allege loss causation. It does not specify how two statements by MSF, as compared to thе complaint’s long list of *1115 alleged misrepresentations and omissions by the executives, proximately caused the investors’ losses.
The complaint alleges thаt the investors suffered damages because they purchased stock at “artificially inflated prices.” This allegation is insufficient under
Dura.
Specifically, a stock’s subsequent loss in value can reflect a variety of factors other than the earlier misstatement.
Dura,
Without these facts, the complaint does not show that the investors’ losses were caused by MSF’s misstatements. This failure is revealing because UCAP’s financial troubles were public knowledge before the announcement of the need for a restatement in April 2004. Sрecifically, in November 2003, UCAP disclosed in an 8-K announcement that its wholly-owned, principal operating subsidiary was in imminent danger of losing its only line of credit and that UCAP had sоld a controlling share of its stock to avoid the subsidiary’s bankruptcy. The complaint’s lack of specific allegations of the value of UCAP stock defeats thе plausibility of the investors’ claim that MSF’s audit opinions in January 2002 and 2003 caused their losses. 3
III.
The judgment of the district court is affirmed.
Notes
. The Honorable Robert T. Dawson, United States District Judge for the Western District of Arkansas.
. The investors assert that MSF is also liable for UCAP’s quarterly reports from the first quarter of 2001 through the second quarter of 2003. They argue that the audit opinion on an annual report opines on the quarterly statements previously issued. However, the quarterly statements did not contain an audit opinion and were not attributed to MSF. Thereforе, the quarterly reports are not MSF’s statements for purposes of Section 10(b).
See Lattanzio v. Deloitte & Touche LLP,
. The parties agree that the investors' claims under the Arkansas securities laws and for common law fraud fail if their Section 10(b) allegations are insufficient to state a claim.
